SEC Form 4 · accession 0000904454-16-001257
Aldeyra Therapeutics, Inc. · ALDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jesse I Treu
Director · 10% Owner
Period of report
Jun 9, 2016
Accepted (ET)
Jun 13, 2016 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001341235
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.97 | Jun 9, 2016 | A | 6,083 | A | Jun 9, 2017 | Jun 8, 2026 | Common Stock | 6,083 | 6,083 | D |
Explanation of responses
- F1The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer through such vesting date.